Ekaterina Boeva

Dr. Ekaterina Boeva

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2018 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
EBEkaterina Boeva
Ekaterina Boeva
NBN. A. Belyakov
N. A. Belyakov
Antiretroviral therapy (ART) leads to suppression of HIV replication, contributes to increase in the number of CD4-lymphocytes count and partial restoration or activation of the immune system. The consequence is a reduction of incidence of opportunistic diseases, increase in the duration and quality of life of people living with HIV (PLHIV). However, in some patients with severe immunosuppression, this may be accompanied by a worsening of the condition and risks of formation of the immune reconstitution inflammatory syndrome (IRIS), which manifests itself in the development of new or previously treated opportunistic, secondary and exacerbating non- infectious diseases against a virologically effective ART. The frequency of the development of IRIS varies widely, in cases of tuberculosis-associated manifestation it can reach 50%. Risk factors for the development of IRIS are low initial CD4-lymphocyte count and a high load of HIV RNA in the blood, the presence of opportunistic infections during the initiation of ART. Discussed terminology issues, other possible risk factors for the development of the syndrome, regularities of the pathological process are considered. Epidemiological statistics of IRIS, pathogenetic bases, variants of clinical and laboratory manifestations of complications are given. The criteria for diagnosis of the syndrome, as well as the necessary conditions for its occurrence, are considered. Particular attention is paid to the most common opportunistic infections that cause the manifestation of IRIS, the peculiarities and polymorphism of clinical manifestations and the prevention of their occurrence. Currently, there is an increasing incidence of HIV infection in the late stages. Laboratory and clinical differences in the manifestations of acquired immunodeficiency syndrome (AIDS) and IRIS have been sanctified. In view of the blurring of the diagnostic criteria, in the Russian Federation specialists rarely expose IRIS to clinical or pathological diagnoses, therefore it is rather difficult to trace the frequency of occurrence of this condition. Clinical and laboratory manifestations are systematized, which allows to formulate this diagnosis on the basis of their totality. Prevention of IRIS is the prudent prescription of antiretroviral drugs. It is neces sary to conduct a qualitative and timely diagnosis of concomitant diseases of infectious and non-infectious nature before the initiation of ART and during treatment, the appointment of effective etiotropic therapy for opportunistic and secon dary infections. In order to improve the prognosis of HIV infection, preferably early onset of ART with stable CD4-lym phocyte counts and low HIV RNA levels in the blood.

Verified
Journal Article
Open access
PDF file
Zoia R. KorobovaZoia R. Korobova
Zoia R. Korobova
NANatalia Arsentieva
Natalia Arsentieva
NLNatalia E. Liubimova
Natalia E. Liubimova
OBOleg K. Batsunov
Oleg K. Batsunov
ABAnastasiya Butenko
Anastasiya Butenko
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Background: Long COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection. This study aims to evaluate immune system markers, including antigen-specific antibodies, B cell subsets, and Th2-related cytokines, in individuals with long COVID and to investigate their potential impact on the development of this condition. Methods: We analyzed blood plasma from 63 individuals diagnosed with long COVID based on clinical presentation and 47 healthy individuals with COVID-19 history but no clinical symptoms. Antigen-specific IgG antibodies were measured using commercial ELISA kits. Lymphocyte subpopulations were assessed via flow cytometry and a gating strategy based on CD27 and CD38. Th2 cytokines (IL-4, IL-5, IL-13) were quantified using the xMAP multiplex assay. Results: We noted no significant differences in IgG levels between groups. Notably, individuals with long COVID demonstrated a higher percentage of naive mature B cells (CD27−CD38+), while transitional (CD27−CD38+++) and double-negative (DN, CD27−CD38-) cells were significantly reduced. Elevated levels of IL-5 and IL-13 were observed in long COVID patients. Classification analysis revealed that the percentage of transitional B cells (CD27−CD38+++) was a strong predictor of long COVID. Conclusions: Our findings highlight alterations in B cell dynamics among individuals with long COVID, which may contribute to autoimmune processes.

Verified
Journal Article
Open access
PDF file
Zoia R. KorobovaZoia R. Korobova
Zoia R. Korobova
NANatalia Arsentieva
Natalia Arsentieva
ABAnastasiya Butenko
Anastasiya Butenko
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
ARArtem Rubinstein
Artem Rubinstein
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Despite targeting mainly the respiratory tract, SARS-CoV-2 disrupts T cell homeostasis in ways that may explain both acute lethality and long-term immunological consequences. In this study, we aimed to evaluate the T-cell-mediated chain of immunity and formation of TCR via TREC assessment in COVID-19 and long COVID (LC). For this study, we collected 231 blood samples taken from patients with acute COVID-19 (n = 71), convalescents (n = 51), people diagnosed with LC (n = 63), and healthy volunteers (n = 46). With flow cytometry, we assessed levels of CD4+ and CD8+ minor T cell subpopulations (i.e., naïve, central and effector memory cells (CM and EM), Th1, Th2, Th17, Tfh, Tc1, Tc2, Tc17, Tc17.1, and subpopulations of effector cells (pE1, pE2, effector cells)). Additionally, we measured TREC levels. We found distinct changes in immune cell distribution—whilst distribution of major subpopulations of T cells was similar between cohorts, we noted that COVID-19 was associated with a decrease in naïve Th and CTLs, an increase in Th2/Tc2 lymphocyte polarization, an increase in CM cells, and a decrease in effector memory cells 1,3, and TEMRA cells. LC was associated with naïve CTL increase, polarization towards Th2 population, and a decrease in Tc1, Tc2, Em2, 3, 4 cells. We also noted TREC correlating with naïve cells subpopulations. Our findings suggest ongoing immune dysregulation, possibly driven by persistent antigen exposure or tissue migration of effector cells. The positive correlation between TREC levels and naïve T cells in LC patients points to residual thymic activity. The observed Th2/Th17 bias supports the hypothesis that LC involves autoimmune mechanisms, potentially driven by molecular mimicry or loss of immune tolerance.

12 November 2020 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
NBN. A. Belyakov
N. A. Belyakov
VRVadim Rassokhin
Vadim Rassokhin
ESE. V. Stepanova
E. V. Stepanova
NSN. V. Sizova
N. V. Sizova
ASA. V. Samarina
A. V. Samarina
RDR. DiKlimenta
R. DiKlimenta
The paper studies key epidemiological, medical, social and economic, and demographic prerequisites determining the necessity of personalized diagnosis and treatment of patients with HIV-infection and comorbid states. Some regularities and sequence of creation of personalized medical care for patients of the Russian Federation were investigated, common characteristics and aspects of each component of personalized check-up and treatment of patients with HIV-infection were presented, separate groups and cohorts of people for whom such approach is essential and acceptable were selected.

30 December 2022 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
EBEkaterina Boeva
Ekaterina Boeva
NBNikolay A. Belyakov
Nikolay A. Belyakov
OSOlga E. Simakina
Olga E. Simakina
DDDaria Danilenko
Daria Danilenko
DLDmitry Lioznov
Dmitry Lioznov
Currently, the disease caused by the new coronavirus (COVID-19) and the possibility of co-infection with SARS-CoV-2 and other pathogens in the current epidemic situation continues to be of particular interest. The review, based on the analysis of literature and own materials, outlines the features of the relationship between SARS-CoV-2 and pathogens of acute respiratory viral infections (ARVI). Particular attention is paid to the combined course of COVID-19 and influenza, a comparative characteristic of the severity of the clinical picture. An assessment of the epidemic situation against the backdrop of the COVID-19 pandemic in foreign countries and the Russian Federation (RF) revealed the presence of the phenomenon of SARS-CoV-2 interference with other viral respiratory agents, based on the facts of a sharp suppression of the circulation of influenza viruses, respiratory syncytial virus (RSV) and other ARVI pathogens during the period of active spread of pandemic coronavirus. The main epidemiological indicators of the course of coronavirus infection were compared and the contribution of various pathogens to the etiology of acute respiratory viral infections during the development of the second wave of COVID-19 in the RF was assessed. It was noted that the decrease in the number of new cases by 11.4 and deaths by 2.1 times due to COVID-19 at 6 and 13 weeks in 2022 occurred with unchanged laboratory detection of the influenza virus (0.8%) and an increase in the frequency detection of pathogens of other SARS. The results of observations showed that against the background of a decrease in the incidence of COVID-19, there was no increase in the proportion of diagnosed cases of infections caused by other pathogens, especially influenza. The results obtained confirm the need to ensure effective epidemiological surveillance and additional application of pathogen identification methods for monitoring various ARVI, which can significantly affect the approach to differential diagnosis, patient management tactics and the decision on appropriate preventive measures.

1 January 2022 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
OGOleg Aleksandrovich Grebenchikov
Oleg Aleksandrovich Grebenchikov
VKV.V. Kulabukhov
V.V. Kulabukhov
ASA.K. Shabanov
A.K. Shabanov
OIO.V. Ignatenko
O.V. Ignatenko
VAViktoriya Vitalievna Antonova
Viktoriya Vitalievna Antonova
AKArtem Kuzovlev
Artem Kuzovlev
ЦЕЛЬЮ Обзора является анализ данных литературы о перспективах и безопасности продленной седации ингаляционными анестетиками с применением устройства для ингаляционной седации испарителя AnaConDa в отделениях интенсивной терапии и реанимации. Анализ результатов исследований показал, что применение продленной ингаляционной седации в отделении реанимации пациентам, находящимся в критическом состоянии, способствует ранней активизации и реабилитации благодаря хорошей управляемости, сокращает время пребывания на искусственной вентиляции легких, оказывает нейропротекторное, кардиопротекторное, противовоспалительное, антиконвульсантное, бронходилатирующее действие, обеспечивая ряд положительных эффектов при относительно простой и безопасной технике выполнения. Можно заключить, что исследователям еще только предстоит установить преимущества или недостатки седации ингаляционными анестетиками по сравнению с седацией внутривенными препаратами в повседневной клинической практике.